ERNA Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 May 2024 @ 16:00):

Stats
Today's Volume	10 908.00
Average Volume	8 136.00
Market Cap	10.04M
EPS	$0 ( 2024-03-13 )
Next earnings date	( $0 ) 2024-05-06
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.450
ATR14	$0.0160 (0.86%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-26	Cicala Peter	Buy	88 946	Stock Option (Right to buy)
2024-04-26	Gurrola Sandra M	Buy	80 000	Stock Option (Right to buy)
2024-04-26	Bristol James Arthur	Buy	124 525	Stock Option (Right to buy)
2024-02-12	Cicala Peter	Buy	0
2024-01-01	Luther Sanjeev	Buy	1 685 218	Stock Option (right to buy)

INSIDER POWER
66.27
Last 79 transactions
Buy: 24 361 048 \| Sell: 3 382 661

Eterna Therapeutics Inc. Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Eterna Therapeutics Inc. Financials

Annual	2023
Revenue:	$68 000.00
Gross Profit:	$-1.29M (-1 898.53 %)
EPS:	$-4.08

FY	2023
Revenue:	$68 000.00
Gross Profit:	$-1.29M (-1 898.53 %)
EPS:	$-4.08

FY	2022
Revenue:	$0
Gross Profit:	$-497 000 (0.00 %)
EPS:	$-8.06

FY	2021
Revenue:	$0.00
Gross Profit:	$0.00 (0.00 %)
EPS:	$-56.40

Financial Reports:

No articles found.

Eterna Therapeutics Inc.

Brooklyn ImmunoTherapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing therapies to treat patients with cancer. Its advanced program is IRX-2 that is in a Phase 2b clinical trial in patients with squamous cell cancer of the head and neck. The company also develops therapies using gene-editing and cell therapy technology for the treatment of oncology, blood disorder, and monogenic disease. Brooklyn ImmunoTherapeutics, Inc. is based in Brooklyn, New York.

Realtime updates for Eterna Therapeutics Inc. [ERNA]

Upcoming Earnings Alert